The Basic Principles Of Oncology products
3872-one: post the final report and datasets from a randomized, period 3 medical trial that verifies and describes the clinical benefit of tazemetostat in sufferers with R/R FL whose tumors are beneficial for an EZH2 mutation as detected by an FDA-permitted examination. The demo must contain adequat